Cargando…
Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
Histone deacetylase inhibitors (HDACi) have been approved and achieved success in hematologic malignancies. But its application in solid tumors still confronts big challenges and is hampered by low treatment efficacy. Nanotechnology has been widely applied in cancer therapy, and nanomedicine could i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284110/ https://www.ncbi.nlm.nih.gov/pubmed/32582697 http://dx.doi.org/10.3389/fcell.2020.00400 |